In our study, the identified cut-off value for albumin was 38.5.g/L; and 23.7% of the patients with EBV-nonHLH and 86.3% of the patients with EBV-HLH had albumin < 38.5.g/L in their first albumin test (P<0.05). This evidence concerns the gene ALB and hemophagocytic syndrome.